|
US5674908A
(en)
|
1993-12-20 |
1997-10-07 |
Life Technologies, Inc. |
Highly packed polycationic ammonium, sulfonium and phosphonium lipids
|
|
US6989434B1
(en)
|
1994-02-11 |
2006-01-24 |
Invitrogen Corporation |
Reagents for intracellular delivery of macromolecules
|
|
WO1998019709A2
(en)
*
|
1996-11-04 |
1998-05-14 |
Qiagen Gmbh |
Cationic reagents for transfection
|
|
EP1129064B1
(en)
|
1998-11-12 |
2008-01-09 |
Invitrogen Corporation |
Transfection reagents
|
|
US7683035B1
(en)
*
|
1999-02-23 |
2010-03-23 |
Qiagen, Gmbh |
Method of stabilizing and/or isolating nucleic acids
|
|
US20030096414A1
(en)
|
2001-03-27 |
2003-05-22 |
Invitrogen Corporation |
Culture medium for cell growth and transfection
|
|
US7906122B2
(en)
|
2003-06-18 |
2011-03-15 |
Yissum Research Development Company Of The Hebrew University Of Jersusalem |
Sphingoid polyalkylamine conjugates for Hepatitis B virus vaccination
|
|
JP4782675B2
(ja)
|
2003-06-18 |
2011-09-28 |
イッスム・リサーチ・ディベロップメント・カンパニー・オブ・ザ・ヘブルー・ユニバーシティ・オブ・エルサレム |
ワクチン接種用スフィンゴイドポリアルキルアミン抱合体
|
|
US20060211004A1
(en)
|
2005-02-15 |
2006-09-21 |
Ilsley Diane D |
Methods and compositions for determining non-specific cytotoxicity of a transfection agent
|
|
EP1871914A4
(en)
*
|
2005-04-01 |
2011-04-27 |
Life Technologies Corp |
METHOD AND COMPOSITIONS FOR INTRODUCING BIOPOLYMERS IN CELLS
|
|
WO2007084342A2
(en)
|
2006-01-13 |
2007-07-26 |
The Government Of The United States, As Represented By The Secretary Of The Department Of Health And Human Services, National Institutes Of Health |
Codon optimi zed il- 15 and il- 15r-alpha genes for expression in mammalian cells
|
|
LT2494993T
(lt)
|
2007-05-04 |
2018-12-27 |
Marina Biotech, Inc. |
Aminorūgščių lipidai ir jų panaudojimas
|
|
WO2009155100A1
(en)
|
2008-05-30 |
2009-12-23 |
Yale University |
Targeted oligonucleotide compositions for modifying gene expression
|
|
US20100112042A1
(en)
|
2008-10-16 |
2010-05-06 |
Mdrna, Inc. |
Processes and Compositions for Liposomal and Efficient Delivery of Gene Silencing Therapeutics
|
|
CA2782676C
(en)
|
2009-12-01 |
2021-06-15 |
Shire Human Genetic Therapies, Inc. |
Pharmaceutical compositions for intracellular delivery of nucleic acids and proteins and uses thereof for treatment of ureca cycle metabolic disorders
|
|
US20130052221A1
(en)
|
2010-02-26 |
2013-02-28 |
The Govt. of the U.S, as represented by The Sec. of The Dept. of Health and Human Services |
Dna-protein vaccination protocols
|
|
WO2011120023A1
(en)
|
2010-03-26 |
2011-09-29 |
Marina Biotech, Inc. |
Nucleic acid compounds for inhibiting survivin gene expression uses thereof
|
|
WO2011133584A2
(en)
|
2010-04-19 |
2011-10-27 |
Marina Biotech, Inc. |
Nucleic acid compounds for inhibiting hras gene expression and uses thereof
|
|
WO2011139842A2
(en)
|
2010-04-28 |
2011-11-10 |
Marina Biotech, Inc. |
Nucleic acid compounds for inhibiting fgfr3 gene expression and uses thereof
|
|
FR2964569B1
(fr)
|
2010-09-10 |
2012-10-19 |
Ct De Cooperation Internationale En Rech Agronomique Pour Le Dev Cirad |
Nouveaux liposomes de vaccination genique
|
|
US8853377B2
(en)
|
2010-11-30 |
2014-10-07 |
Shire Human Genetic Therapies, Inc. |
mRNA for use in treatment of human genetic diseases
|
|
NZ703649A
(en)
|
2010-12-06 |
2016-08-26 |
Penn State Res Found |
Compositions and methods relating to proliferative diseases
|
|
CA3107288A1
(en)
|
2011-06-08 |
2012-12-13 |
Translate Bio, Inc. |
Lipid nanoparticle compositions and methods for mrna delivery
|
|
ES2567091T3
(es)
|
2012-04-05 |
2016-04-19 |
F. Hoffmann-La Roche Ag |
Compuestos de amina para la preparación selectiva de muestras biológicas
|
|
EP2859102A4
(en)
|
2012-06-08 |
2016-05-11 |
Shire Human Genetic Therapies |
NUCLEASE RESISTANT POLYNUCLEOTIDES AND USES THEREOF
|
|
MX365409B
(es)
|
2013-03-14 |
2019-05-31 |
Shire Human Genetic Therapies |
Composiciones de ácido ribonucleico mensajero del regulador transmembrana de fibrosis quística y métodos y usos relacionados.
|
|
EA201591229A1
(ru)
|
2013-03-14 |
2016-01-29 |
Шир Хьюман Дженетик Терапис, Инк. |
Способы очистки матричной рнк
|
|
CA2905696A1
(en)
|
2013-03-15 |
2014-09-18 |
The Penn State Research Foundation |
Compositions and methods including leelamine and arachidonyl trifluoromethyl ketone relating to treatment of cancer
|
|
WO2014143031A1
(en)
|
2013-03-15 |
2014-09-18 |
The Penn State Research Foundation |
Compositions and methods including celecoxib and plumbagin relating to treatment of cancer
|
|
EP3060303B1
(en)
|
2013-10-22 |
2018-11-14 |
Translate Bio, Inc. |
Mrna therapy for argininosuccinate synthetase deficiency
|
|
MX2016005239A
(es)
|
2013-10-22 |
2016-08-12 |
Shire Human Genetic Therapies |
Tratamiento con acido ribonucleico mensajero para la fenilcetonuria.
|
|
KR20250005450A
(ko)
|
2014-04-25 |
2025-01-09 |
샤이어 휴먼 지네틱 테라피즈 인크. |
메신저 rna 의 정제 방법
|
|
WO2016011203A1
(en)
|
2014-07-15 |
2016-01-21 |
Life Technologies Corporation |
Compositions with lipid aggregates and methods for efficient delivery of molecules to cells
|
|
EA201991747A1
(ru)
|
2017-02-27 |
2020-06-04 |
Транслейт Био, Инк. |
НОВАЯ КОДОН-ОПТИМИЗИРОВАННАЯ мРНК CFTR
|
|
CA3063531A1
(en)
|
2017-05-16 |
2018-11-22 |
Translate Bio, Inc. |
Treatment of cystic fibrosis by delivery of codon-optimized mrna encoding cftr
|
|
EP3841208A1
(en)
|
2018-08-24 |
2021-06-30 |
Translate Bio, Inc. |
Methods for purification of messenger rna
|
|
MX2021005969A
(es)
|
2018-11-21 |
2021-09-14 |
Translate Bio Inc |
Tratamiento de la fibrosis quística mediante el suministro de arnm que codifica cftr nebulizado.
|
|
CA3137727A1
(en)
|
2019-04-22 |
2020-10-29 |
The Penn State Research Foundation |
Methods and compositions relating to inhibition of aldehyde dehydrogenases for treatment of cancer
|
|
CN114656422B
(zh)
*
|
2022-04-22 |
2023-05-23 |
重庆理工大学 |
一种新型氮杂冠醚化合物及其阳离子脂质体、制备方法与应用
|
|
EP4532750A1
(en)
|
2022-06-02 |
2025-04-09 |
Revvity Health Sciences, Inc. |
Electrophoresis-mediated characterization of dna content of adeno-associated virus capsids
|